Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Frank

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Cardiology|June 1, 1990
The safety profile of quinapril: is there a difference among ACE inhibitors?D Canter, G J Frank, L E Knapp, et al.
Journal of Human Hypertension|March 1, 1994
Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator GroupD Canter, G J Frank, L E Knapp, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
The safety and tolerability of quinaprilL E Knapp, G J Frank, R McLain, et al.
Clinical and Experimental Dermatology|August 12, 2006
Human orf complicated by mucous membrane pemphigoidR G van Lingen, R G J Frank, R J J Koopman, et al.
British Journal of Clinical Pharmacology|August 1, 1990
The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairmentE J Begg, R A Robson, R R Bailey, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1989
The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairmentE J Begg, R R Bailey, K L Lynn, et al.
European Journal of Dermatology : EJD|September 21, 2005
Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in EuropeHarald Gollnick, Carlos Guillén Barona, Ronald G J Frank, et al.
British Journal of Clinical Pharmacology|January 1, 1986
A comparison of isoxicam pharmacokinetics in young and elderly subjectsC F George, A G Renwick, A S Darragh, et al.
Biopharmaceutics & Drug Disposition|April 1, 1990
Multiple-dose propranolol administration does not influence the single dose pharmacokinetics of quinapril and its active metabolite (quinaprilat)A M Horvath, D Pilon, G Caillé, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
Overview of quinapril, a new ACE inhibitorG J Frank, L E Knapp, S C Olson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Cardiology|June 1, 1990
The safety profile of quinapril: is there a difference among ACE inhibitors?D Canter, G J Frank, L E Knapp, et al.
Journal of Human Hypertension|March 1, 1994
Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator GroupD Canter, G J Frank, L E Knapp, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
The safety and tolerability of quinaprilL E Knapp, G J Frank, R McLain, et al.
Clinical and Experimental Dermatology|August 12, 2006
Human orf complicated by mucous membrane pemphigoidR G van Lingen, R G J Frank, R J J Koopman, et al.
British Journal of Clinical Pharmacology|August 1, 1990
The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairmentE J Begg, R A Robson, R R Bailey, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1989
The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairmentE J Begg, R R Bailey, K L Lynn, et al.
European Journal of Dermatology : EJD|September 21, 2005
Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in EuropeHarald Gollnick, Carlos Guillén Barona, Ronald G J Frank, et al.
British Journal of Clinical Pharmacology|January 1, 1986
A comparison of isoxicam pharmacokinetics in young and elderly subjectsC F George, A G Renwick, A S Darragh, et al.
Biopharmaceutics & Drug Disposition|April 1, 1990
Multiple-dose propranolol administration does not influence the single dose pharmacokinetics of quinapril and its active metabolite (quinaprilat)A M Horvath, D Pilon, G Caillé, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
Overview of quinapril, a new ACE inhibitorG J Frank, L E Knapp, S C Olson, et al.
Pageof 2